Risk of gastric cancer in autoimmune gastritis and pernicious anaemia: Insights from Mendelian randomization and multi-omics analysis

Abstract

Background: The newly onset debate surrounding the risk of gastric cancer (GC) in autoimmune gastritis (AIG) and pernicious anaemia has intensified. It is necessary to supplement higher level research evidences to settle this issue.

Methods: Two-sample Mendelian randomization (MR) analysis using inverse variance weighted method was conducted to reveal the causal relationship between pernicious anaemia and GC. Because of the absence of available summary statistics for AIG at present, we used pernicious anaemia as a proxy exposure, as it was frequently used interchangeably. The multi-omics characteristics of AIG and pernicious anaemia were further explored through proteome-wide MR, colocalization, and transcriptome sequencing analysis.

Results: MR analysis found pernicious anaemia was causally associated with a higher risk of GC (odds ratio: 1.16, 95% confidence interval [1.03, 1.31], p = .018). Sensitivity analyses confirmed the stability of the results. The up-regulation of genes involved in gastric dysplasia and carcinogenesis, including receptor activity-modifying protein 3, fibroblast growth factor 3, transforming growth factor beta-2 and tumour-associated calcium signal transducer 2, suggested potential mechanisms underlying the risk of GC in AIG.

Conclusions: These results emphasized the independent link fromAIG and pernicious anaemia to GC. Therefore, endoscopy follow-up for GC screening in AIG is still appealed.

Keywords

autoimmune gastritis / carcinogenesis / gastric cancer / Mendelian randomization / pernicious anaemia

References

[1] LentiMV, RuggeM, LahnerE, et al. Autoimmune gastritis. Nat Rev Dis Primers. 2020;6:56.

[2] GreenR, AllenLH, Bjørke-MonsenA-L, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040.

[3] VannellaL, LahnerE, OsbornJ, et al. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013;37:375-382.

[4] RuggeM, BriccaL, GuzzinatiS, et al. Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients. Gut. 2023;72:30-38.

[5] MiceliE, LentiMV, GentileA, et al. Long-term natural history of autoimmune gastritis: results from a prospective monocentric series. Am J Gastroenterol. 2024;119:837-845.

[6] GoldenringJ. No H. pylori, no adenocarcinoma for patients with autoimmune gastritis. Gut. 2023;72:1-2.

[7] DilaghiE, Dottori L, PivettaG, et al. Incidence and predictors of gastric neoplastic lesions in corpus-restricted atrophic gastritis: a single-center cohort study. Am J Gastroenterol. 2023;118:2157-2165.

[8] WaldumHL. Conclusion that autoimmune gastritis does not predispose to gastric cancer is unproven. Gut. 2024;73:379.

[9] SekulaP, Del Greco M F, PattaroC, et al. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27:3253-3265.

[10] KurkiMI, Karjalainen J, PaltaP, et al. Finngen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508-518. doi:10.1038/s41586-022-05473-8

[11] JiangL, ZhengZ, FangH, et al. A generalized linear mixed model association tool for biobank-scale data. Nat Genet. 2021;53:1616-1621.

[12] BurgessS, DaviesNM, ThompsonSG. Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016;40:597-608.

[13] FerkingstadE, SulemP, AtlasonBA, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53:1712-1721.

[14] KamatMA, Blackshaw JA, YoungR, et al. PhenoScanner V2:an expanded tool for searching human genotype–phenotype associations. Bioinformatics. 2019;35:4851-4853.

[15] SollisE, MosakuA, AbidA, et al. The NHGRI-EBI GWAS catalog: knowledgebase and deposition resource. Nucleic Acids Res. 2023;51:D977-D985.

[16] ZhaoJ, MingJ, HuX, et al. Bayesian weighted Mendelian randomization for causal inference based on summary statistics. Bioinformatics. 2020;36:1501-1508.

[17] XueH, ShenX, PanW. Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. Am J Hum Genet. 2021;108:1251-1269.

[18] VerbanckM, MRPRESSO: Performs the Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO) test. R package version 1.0. 2017. https://mrcieu.r-universe.dev/MRPRESSO/citation.html

[19] BowdenJ, Davey Smith G, HaycockPC, et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304-314.

[20] GuZ. Complex heatmap visualization. Imeta. 2022;1:e43.

[21] TakeuchiC, SatoJ, YamamichiN, et al. Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation. J Gastroenterol. 2024;59:95-108.

[22] LentiMV, Broglio G, SabatinoAD. Unravelling the risk of developing gastric cancer in autoimmune gastritis. Gut. 2023;72:1429-1430.

[23] RustgiSD, Bijlani P, ShahSC. Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management. Therap Adv Gastroenterol. 2021;14:17562848211038771.

[24] TwH, KzT, ThO. Pernicious anemia: pathophysiology and diagnostic difficulties. J Evid-Based Med. 2021;14:161-169.

[25] WadhwaR, SongS, LeeJ-S, et al. Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10:643-655.

[26] Nabavi-RadA, Sadeghi A, Asadzadeh AghdaeiH, et al. The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management. Gut Microbes. 2022;14:2108655.

[27] TakeuchiC, SatoJ, YamashitaS, et al. Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potential. J Gastroenterol. 2022;57:144-155.

[28] MeyerAR, Engevik AC, MadorskyT, et al. Group 2 innate lymphoid cells coordinate damage response in the stomach. Gastroenterology. 2020;159:2077-2091.

[29] HoftSG, Brennan M, CarreroJA, et al. Unveiling cancer-related metaplastic cells in both helicobacter pylori infection and autoimmune gastritis. Gastroenterology. 2025;168(1):53-67.

[30] AraiJ, Niikura R, HayakawaY, et al. Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis. Gut. 2023;73:1037–1038.

[31] HessT, MajC, GehlenJ, et al. Dissecting the genetic heterogeneity of gastric cancer. EBioMedicine. 2023;92:104616.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.